Column Group L P Nurix Therapeutics, Inc. (NRIX) insider trading activity

NRIX Quotes by TradingView

Column Group L P is > 10% Shareholder of Nurix Therapeutics, Inc.. Currently has a direct ownership of 1.39 Million shares of NRIX, which is worth approximately $29 Million. The most recent transaction as insider was on May 05, 2021, when has been sold 2,000,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.39M
0% 3M change
0% 12M change
Total Value Held $29 Million

COLUMN GROUP L P Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 05 2021
SELL
Other acquisition or disposition
-
2,000,000 Reduced 58.92%
1,394,333 Common Stock
May 05 2021
SELL
Other acquisition or disposition
-
2,000,000 Reduced 58.92%
1,394,333 Common Stock
Jul 28 2020
BUY
Conversion of derivative security
-
6,672,548 Added 90.67%
686,274 Common Stock

Also insider at

IMDZ
IMMUNE DESIGN CORP.
> 10% Shareholder
CNST
CONSTELLATION PHARMACEUTICALS INC Healthcare
> 10% Shareholder
NGM
NGM BIOPHARMACEUTICALS INC Healthcare
Director
CGL

Column Group L P

> 10% Shareholder
San Francisco, CA

Track Institutional and Insider Activities on NRIX

Follow Nurix Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NRIX shares.

Notify only if

Insider Trading

Get notified when an Nurix Therapeutics, Inc. insider buys or sells NRIX shares.

Notify only if

News

Receive news related to Nurix Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NRIX